RF
AZN icon

Robinswood Financial’s AstraZeneca AZN Stock Holding History

Robinswood Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7K Hold
109
– – 0.01% 235
2026
Q1 		$21.5K Sell
109
-1
-0.9% -$193 0.01% 217
2025
Q4 		$20.1K Hold
110
– – 0.01% 221
2025
Q3 		$16.8K Hold
110
– – 0.01% 227
2025
Q2 		$15.3K Hold
110
– – 0.01% 233
2025
Q1 		$16.1K Buy
+110
New +$15.9K 0.01% 211
2024
Q3 		– Sell
-54
Closed -$8.49K – 362
2024
Q2 		$8.49K Buy
+54
New +$8.13K ﹤0.01% 220

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Robinswood Financial's AZN Position: Q2 2026 in Review

Robinswood Financial held its AstraZeneca (AZN) position steady in Q2 2026 at 109 shares worth $20.7K. The position accounts for 0.01% of the portfolio, ranked #235.

Robinswood Financial first reported a position in AZN in Q2 2024 and has held it in 7 quarters since. The position peaked at $21.5K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Robinswood Financial held 109 shares of AstraZeneca worth $20.7K as of Q2 2026.
  • Robinswood Financial left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of Robinswood Financial's portfolio in Q2 2026, its #235 holding.
  • Robinswood Financial first reported a position in AstraZeneca in Q2 2024 and has held it in 7 quarters since.
  • Robinswood Financial's AstraZeneca position peaked at $21.5K in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.